NOTV
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
P/E is N/A; Graham Number cannot be calculated due to negative earnings.
- P/S of 0.02
- P/B of 0.08
- Metrics reflect a 'value trap' rather than a bargain
- Lack of earnings to support valuation
Revenue growth is stagnant at 0.80%, failing to offset operating losses.
- Marginal YoY revenue growth
- Q/Q EPS growth of -295.2%
- Consistent earnings misses
Long-term trend is a near-total loss of shareholder value.
- 5Y Change: -98.8%
- 1Y Change: -84.2%
Severe distress; Altman Z-Score not provided but liquidity ratios signal imminent risk.
- Piotroski F-Score 1/9
- Debt/Equity 4.37
- Current Ratio 0.30
Dividend Yield: N/A
- No dividend paid
- No capacity for dividends
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for NOTV and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
NOTV
Inotiv, Inc.
Primary
|
-98.8% | -95.0% | -84.2% | -82.6% | -31.9% | -2.0% |
|
GELS
Gelteq Limited
Peer
|
-73.9% | -73.9% | -14.8% | -43.5% | +3.7% | +13.2% |
|
IMRN
Immuron Limited
Peer
|
-85.9% | -59.6% | -51.9% | -61.7% | -3.3% | -1.0% |
|
EVGN
Evogene Ltd.
Peer
|
-98.3% | -86.8% | -23.5% | -45.0% | +5.7% | -0.8% |
|
ALUR
Allurion Technologies Inc.
Peer
|
-99.8% | -99.8% | -84.6% | -75.5% | -69.7% | -11.7% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
NOTV
Inotiv, Inc.
|
BEARISH | $8.43M | - | -49.8% | -13.5% | $0.24 | |
|
GELS
Gelteq Limited
|
BEARISH | $8.23M | - | -43.0% | -% | $0.77 | Compare |
|
IMRN
Immuron Limited
|
BEARISH | $8.1M | - | -39.7% | -62.1% | $0.79 | Compare |
|
EVGN
Evogene Ltd.
|
BEARISH | $7.95M | - | -100.7% | -220.2% | $0.8 | Compare |
|
ALUR
Allurion Technologies Inc.
|
BEARISH | $7.92M | - | -% | -187.9% | $0.53 | Compare |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-17 | TAYLOR BETH A | Chief Financial Officer | Sale | 2,888 | $846 |
| 2026-02-17 | SAGARTZ JOHN E | Officer | Sale | 2,119 | $616 |
| 2026-02-17 | LEASURE ROBERT JR. | Chief Executive Officer | Sale | 16,810 | $4,964 |
| 2026-02-02 | LEASURE ROBERT JR. | Chief Executive Officer | Sale | 113,297 | $57,034 |
| 2025-12-01 | NEFF R MATTHEW | Director | Sale | 2,000 | $1,771 |
| 2025-11-03 | NEFF R MATTHEW | Director | Sale | 2,000 | $2,487 |
| 2025-10-24 | NEFF R MATTHEW | Director | Option Exercise | 10,000 | $19,400 |
Wall Street Analysts
Professional analyst ratings and price targets
Past News Coverage
Recent headlines mentioning NOTV from our newsroom.